Is Cirrhosis of the Liver Experimentally Produced by Cc14 An Adequate Model of Human Cirrhosis?
1983; Lippincott Williams & Wilkins; Volume: 3; Issue: 1 Linguagem: Inglês
10.1002/hep.1840030118
ISSN1527-3350
Autores Tópico(s)Liver Disease and Transplantation
ResumoHepatologyVolume 3, Issue 1 p. 112-120 ArticleFree Access Is Cirrhosis of the Liver Experimentally Produced by CC14 an Adequate Model of Human Cirrhosis? Ruy Perez Tamayo, Corresponding Author Ruy Perez Tamayo Department of Pathology, Instituto Nacional de la Nutritión "Salvador Zubirán", Vasco de Quiroga 15, Delegatión Tlalpan, 14000 Mexico, D.F. MexicoRuy Pérez Tamayo, M.D., Department of Pathology, Instituto Nacional de la Nutrición "Salvador Zubirán", Vasco de Quiroga 15, Delegatión Tlalpan, 14000 México, D.F. Mexico.===Search for more papers by this author Ruy Perez Tamayo, Corresponding Author Ruy Perez Tamayo Department of Pathology, Instituto Nacional de la Nutritión "Salvador Zubirán", Vasco de Quiroga 15, Delegatión Tlalpan, 14000 Mexico, D.F. MexicoRuy Pérez Tamayo, M.D., Department of Pathology, Instituto Nacional de la Nutrición "Salvador Zubirán", Vasco de Quiroga 15, Delegatión Tlalpan, 14000 México, D.F. Mexico.===Search for more papers by this author First published: 1983 https://doi.org/10.1002/hep.1840030118Citations: 202AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Cameron GR, Karunaratne WAE. Carbon tetrachloride cirrhosis in relation to liver regeneration. J Pathol Bacteriol 1936; 42: 1– 21. 2 Lacquet AM. Experimental pathology of the liver: effects of carbon tetrachloride on the normal and on the restored liver often partial hepatectomy. Arch Pathol 1932; 14: 164– 174. 3 Lamson PD, Wing R. Early cirrhosis of the liver produced in dogs by carbon tetrachloride. J Pharmacol Exp Therap 1926; 29: 191– 202. 4 Bollman JL, Mann FC. Experimentally produced lesions of the liver. Ann Intern Med 1931; 5: 699– 712. 5 Hartroft WS. Experimental cirrhosis. In: C Rouiller, ed. The liver: morphology, biochemistry, physiology. New York: Academic Press, 1964: 477– 514. 6 Popper H. Pathologic aspects of cirrhosis. Am J Pathol 1977; 87: 228– 258. 7 Leevy CM, Popper H, Sherlock S (Criteria Committee). Diseases of the liver and biliary tract: standardization and nomenclature, diagnostic criteria, and diagnostic methodology. Fogarty International Center Proceedings, No. 22, DHEW Publication Number (NIH) 76– 725. Washington, D.C.: U.S. Printing Office, 1976. 8 Popper H, Undenfriend S. Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med 1970; 49: 707– 721. 9 Popper H, Becker K. Collagen metabolism in the liver. New York: Stratton, 1975. 10 Rojkind M, Kershenobich D. Hepatic fibrosis. In: H Popper, F Schaffner, eds. Progress in liver diseases, Vol V. New York: Grune & Stratton, 1976: 294– 310. 11 Popper H, Piez K. Collagen metabolism in the liver. Dig Dis 1978; 23: 641– 659. 12 Rojkind M, Dunn MA. Hepatic fibrosis. Gastroenterol 1979; 76: 849– 863. 13 Rauterbeg J, Voss B, Pott G, et al. Connective tissue components of the normal and fibrotic liver. Klin Wochenschr 1981; 59: 767– 779. 14 Rojkind M, Kershenobich, D. Hepatic fibrosis. In: IM Arias, M Frenkel, JHP Wilson, eds. The liver, Vol 1. Amsterdam: Ex-cerpta Medica, 1981. 15 Rojkind M, Kershenobich D. Hepatic fibrosis. Clin Gastroenterol 1981; 10: 737– 754. 16 Perez Tamayo R. Cirrhosis of the liver: a reversible disease? In: SC Sommers, PP Rosen, eds. Pathology annual, Vol 2 New York: Appleton-Century-Crofts, 1979: 183– 213. 17 McLean EK, McLean AEM, Sutton PM. Instant cirrhosis. Br J Exp Path 1969; 50: 502– 506. 18 Jorgensen M, Norgaard T, Faarup P. Functional structure of the cirrhotic liver. Acta Pathol Microbiol Scand 1974; 82: 13– 20. 19 Daniel PM, Prichard ML, Reynoll PC. The portal circulation in experimental cirrhosis of the liver. J Pathol Bacteriol 1952; 64: 53– 60. 20 Warren WD, Restrepo JE. Portal circulation in experimental cirrhosis. Surg Gynecol Obstet 1962; 114: 563– 567. 21 Rubin E, Hutterer F, Popper H. Cell proliferation and fiber formation in chronic carbon tetrachloride intoxication. Am J Pathol 1963; 42: 715– 724. 22 Popper H, Lieber CS. Histogenesis of alcoholic cirrhosis in the baboon. Am J Pathol 1980; 98: 695– 710. 23 Kent G, Schneider KA. Cirrhosis and iron overload. In: F Schaffner, S Sherlock, CM Leevy, eds. The liver and its diseases. New York: Intercontinental Medical Book Corp., 1974: 283– 288. 24 Kent G, Bahu RM. Iron overload. In: RNM MacSween, PP Anthony, PJ Scheuer, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1979: 148– 163. 25 Ishak KG, Sharp HL. Metabolic errors and liver disease. In: RNM MacSween, PP Anthony, PJ Scheuer, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1979: 88– 147. 26 Doehlert CAJ, Baggenstoss AH, Cain JC. Obstructive biliary cirrhosis and alcoholic cirrhosis: Comparison of clinical and pathologic features. Am J Clin Pathol 1955; 25: 902– 914. 27 Desmet VJ. Cholestasis; extrahepatic obstruction and secondary biliary cirrhosis. In: RNM MacSween, PP Anthony, PJ Scheuer, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1979: 272– 305. 28 Baggenstoss AH, Soloway RD, Summerskill WHJ, et al. Schoen-field LJ. Chronic active liver disease: the range of histologic lesions, their response to treatment, and evolution. Hum Pathol 1972; 3: 183– 198. 29 Aterman K. Studies in fibrosis of the liver induced by carbon tetrachloride. I. Relation between hepatocellular injury and new formation of fibrous tissue. Arch Pathol 1954; 57: 1– 11. 30 Ashburn LL, Endicott KM, Daft FS, et al. The nonportal distribution of the trabeculae in dietary cirrhosis of rats and in carbon tetrachloride cirrhosis of rats and guinea pigs. Am J Pathol 1947; 23: 159– 165. 31 Rappaport AM, Hiraki GY. The anatomical pattern of lesions in the liver. Acta Anat 1958; 32: 126– 140. 32 Bras G, Brandt K-H. Vascular disorders. In: RNM MacSeween, PP Anthony, PJ Scheuer, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1979: 313– 334. 33 Pérez Tamayo R. Enfermedad veno-oclusiva del higado. Patologia 1981; 19: 277– 284. 34 Edmondson HA, Peters RL, Reynolds TB, et al. Sclerosing hyalin necrosis of the liver in the chronic alcoholic: a recognizable clinical syndrome. Ann Intern Med 1963; 59: 646– 673. 35 Baptista A, An International Group. Alcoholic liver disease: morphological manifestations. Lancet 1981; 1: 707– 711. 36 Stenger RJ. Hepatic sinusoids in carbon tetrachloride induced cirrhosis. An electron microscopic study. Arch Pathol 1966; 81: 439– 447. 37 Rubin E, Krus S, Popper H. Pathogenesis of postnecrotic cirrhosis in alcoholics. Arch Pathol 1962; 73: 288– 299. 38 Popper H, Stern R. Reactions of the liver to injury: fibrosis. In: E Farber, MM Fisher, eds. Toxic injury of the liver, Part A. New York: Marcel Dekker, 1979: 243– 280. 39 Edwards JE, Dalton AJ. Induction of cirrhosis of the liver and hepatomas in mice with carbon tetrachloride. J Natl Cancer Inst 1945; 3: 19– 41. 40 Eschenbrenner AB, Miller E. Liver necrosis and the induction of carbon tetrachloride hepatomas in strain A mice. J Natl Cancer Inst 1945; 6: 325– 341. 41 Stowell RE, Lee CS, Tsuboi KK, et al. Histochemical and micro-chemical changes in experimental cirrhosis and hepatoma formation in mice by carbon tetrachloride. Cancer Res 1951; 11: 345– 354. 42 Quinn PS, Higginson J. Reversible and irreversible changes in experimental cirrhosis. Am J Pathol 1965; 47: 353– 364. 43 Faber E. Response of the liver to carcinogens: a new analytical approach. In: E Farber, MM Fisher, eds. Toxic injury of the liver, Part A. New York: Marcel Dekker, 1979: 445– 467. 44 Farber E. Chemical carcinogenesis. N Engl J Med 1981; 305: 1379– 1389. 45 Lee FI. Cirrhosis and hepatoma in alcoholics. Gut 1966; 7: 77– 85. 46 Shikata T. Primary liver carcinoma and liver cirrhosis. In: K Okuda, RL Peters, eds. New York: John Wiley & Sons, 1976: 53– 71. 47 Anthony PP. Hepatic neoplasms. In: RNM MacSween, PP Anthony, PJ Scheuer, eds. Pathology of the liver. Edinburgh: Churchill Livingstone, 1979: 387– 413. 48 Purtilo DT, Gottlieb LS. Cirrhosis and hepatoma occurring at Boston City Hospital (1917–1968). Cancer 1973; 32: 458– 462. 49 Ramos Martinez E, Gonzalez Quesada A, Castillo Foncerrada G, et al. Carcinoma primario del higado. Estudio anatomoclinico de 109 casos. Rev Invest Clin (Mexico) 1982; 34: 133– 143. 50 Morrione TG. Quantitative study of collagen content in experimental cirrhosis. J Exp Med 1947; 85: 217– 225. 51 Morrione TG. Factors influencing collagen content in experimental cirrhosis. Am J Pathol 1949; 25: 273– 280. 52 Lowry OH, Gilligan DR, Katersky EM. The determination of collagen and elastin in tissue, with results obtained in various normal tissues from different species. J Biol Chem 1941; 139: 795– 804. 53 Newman RE, Logan MA. The determination of hydroxyproline. J Biol Chem 1950; 184: 299– 306. 54 Woessner JF. The determination of hydroxyoproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem 1961; 93: 440– 447. 55 Rojkind M, Gonzalez E. An improved method for determining specific radioactivities of proline –14C and hydroxyproline –14C in collagen and in noncollagenous proteins. Ann Biochem 1974; 57: 1– 7. 56 Aterman K. Studies in fibrosis of the liver induced by carbon tetrachloride. II. A quantitative study of the effect of cortisone on fibrosis of the liver in rats. Arch Pathol 1954; 57: 12– 25. 57 Rubin E, Hutterer F, Popper H. Cell proliferation and fiber formation in chronic carbon tetrachloride intoxication. A morphologic and chemical study. Am J Pathol 1963; 42: 715– 724. 58 Ito I. Biochemical studies on connective tissue. I. Proliferation and resorption of the connective tissue in experimental liver cirrhosis. Kunamoto Med J 1964; 17: 67– 78. 59 Hirayama C, Hiroshige K, Masuya T. Hepatic collagenolytic activity in rats after carbon tetrachloride poisoning Biochem J 1969; 115: 843– 847. 60 Maros T, Seres-Stum L, Lakatos O, et al. Investigations regarding the possibility of resorption of the hepatic collagen in experimental toxic cirrhosis, under the effect of "essential" phospholipids. Arz-neim Forsch 1973; 23: 1538– 1542. 61 Risteli J, Kivirikko KI. Activities of prolyl hydroxylase, lysil hydroxylase, collagen galactosyltransferase and collagen glucosyl-transferase in the liver of rats with hepatic injury. Biochem J 1974; 144: 115– 122. 62 Paquet KJ, Kamphausen U. The carbon-tetrachloride-hepatotox-icity as a model of liver damage. Acta Hepato-Gastroenterol 1975; 22: 84– 88. 63 Ruiz-Torres A, Küerten I, Rosenstock M. The dynamics of collagen deposition in liver damaged by CCI4. Beitr Path 1976; 158: 287– 295. 64 Siegel RC, Chen KH, Greenspan JS, et al. Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat. Proc Natl Acad Sci USA 1978; 75: 2945– 2949. 65 Devenyi R, Tiefenbach H, Orrego H, et al. Does an excess of liver proline increase the accumulation of collagen induced by carbon tetrachloride?. Experientia 1979; 35: 1641– 1642. 66 Seyer JM. Interstitial collagen porlymorphism in rat liver with CCL-induced cirrhosis. Biochim Biophys Acta 1980; 629: 490– 498. 67 Ehrinpreiss MN, Giambrone MA, Rojkind M. Liver proline oxidase activity and collagen synthesis in rats with cirrhosis induced by carbon tetrachloride. Biochim Biophys Acta 1980; 629: 184– 193. 68 Hutterer F, Eisenstaldt M, Rubin E. Turnover of hepatic collagen in reversible and irreversible fibrosis. Experientia 1970; 26: 244– 245. 69 Rojkind M, Giambrone MA, Biempica L. Collagen types in normal and cirrhotic liver Gastroenterol 1979; 76: 710– 719. 70 Nowack H, Gay S, Wick G, et al. Preparation and use in immuno-histology of antibodies specific for type I and type III collagen and procollagen. J Immunol Methods 1976; 12: 117– 124. 71 Wick G, Brunner H, Penner E, et al. The diagnostic application of specific antiprocollagen sera. II. Analysis of liver biopsies. Internat Arch Allergy Appl Immunol 1978; 56: 316– 324. 72 Biempica L, Morecki R, Wu CH, et al. Immunocytochemical localization of type B collagen, a component of basement membrane in human liver. Am J Pathol 1980; 98: 591– 602. 73 Gay S, Fietzek PP, Remberger K, et al. Liver cirrhosis. Immuno-fluorescense and biochemical studies demonstrate two types of collagen. Klin Wochenschr 1975; 53: 205– 208. 74 Gay S. Collagen in liver fibrosis. Ital J Gastroenterol 1980; 12: 30– 32. 75 Voss B, Rauterberg J, Allam S, et al. Distribution of collagen type I and type III and of two collagenous components of basement membranes in the human liver. Pathol Res Pract 1980; 170: 50– 60. 76 Grimaud JA, Druguet M, Peyrol S, et al. Collagen immunotyping in human liver: light and electron microscope study. J Histochem Cytochem 1980; 28: 1145– 1156. 77 Konomi H, Sano J, Nagai Y. Immunohistochemical localization of type I, III and IV (basement membrane) collagens in the liver. Acta Pathol Japon 1981; 31: 973– 978. 78 Sano J, Sato S, Ishizaki M, et al. Types I, III and IV (basement membrane) collagens in the bovine liver parenchyma: electron microscopic localization by the peroxidase-labeled antibody method. Biomed Res 1981; 2: 546– 551. 79 Timpl R. Immunological studies on collagen. In: GN Ramachandran, AH Reddi, eds. Biochemistry of collagen. New York: Plenum Press, 1976: 319– 376. 80 Kent G, Gay S, Inouye T, et al. Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA 1976; 73: 3719– 3722. 81 Seyer JM, Hutcheson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977; 59: 241– 248. 82 Rojkind M, Pérez Tamayo R. Liver fibrosis. Internat Rev Connect Tissue Res 1984; 10 (in press). 83 Huberman A, Recio A, Rojkind M. Collagen biosynthesis in normal and cirrhotic rat liver slices. Proc Soc Exp Biol Med 1969; 131: 200– 203. 84 Rojkind M, Díaz de León L. Collagen biosynthesis in cirrhotic rat liver slices: a regulatory mechanism. Biochim Biophys Acta 1970; 217: 512– 522. 85 Galligani L, Lonati-Galligani M, Fuller G. Collagen metabolism in the liver of normal and carbon tetrachloride treated rats. Biome-dicine 1979; 31: 199– 201. 86 Hirayama C, Kimura N, Irisa T, et al. Hepatic collagen and non-collagen protein synthesis in man with and without liver disease. Clin Chim Acta 1968; 21: 49– 54. 87 Chen TSN, Leevy CM. Collagen biosynthesis in liver disease of the alcoholic. J Lab Clin Med 1975; 85: 103– 112. 88 Mann SW, Fuller GC, Redil JV, et al. Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease. Gut 1979; 20: 825– 832. 89 Peterkofsky B, Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971; 10: 988– 994. 90 Työppönen J, Forsander OA, Kulonen E. Influence of extracellular proline on collagen synthesis in rat liver slices. Scand J Gastroenterol 1980; 15: 373– 376. 91 Tanner MS, Jackson D, Mowat AP. Hepatic collagen synthesis in a rat model of cirrhosis, and its modification by colchicine. J Pathol 1981; 135: 179– 187. 92 McPhie JL, Short LT. Hepatic prolyl hydroxylase in experimental cirrhosis. Acta Hepato-Gastroenterol 1975; 22: 387– 391. 93 McGee JO'D, Patrick RS, Marion CR, et al. Collagen proline hydroxylase activity and 35S sulphate uptake in human liver biopsies. Gut 1974; 15: 260– 267. 94 Fuller GC, Nolan JC, Fink S, et al. Prolyl hydroxylase activity in normal and diseased human liver. Proc Soc Exp Biol Med 1976; 151: 61– 64. 95 Jain S, Scheuer PJ, McGee JO'D, et al. Hepatic collagen proline hydroxylase activity in primary biliary cirrhosis. Eur J Clin Invest 1978; 8: 15– 17. 96 Mezey E, Potter JJ, Maddrey WC. Hepatic collagen prolyl hydroxylase activity in alcholic liver disease. Clin Chim Acta 1976; 68: 313– 320. 97 Mezey E, Potter JJ, Iber FL, et al. Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: effect of d-penicillamine. J Lab Clin Med 1979; 93: 92– 100. 98 Mezey E, Imbembo AL. Hepatic collagen proline hydroxylase activity in hepatic disease following jejunoileal bypass for morbid obesity. Surgery 1978; 83: 345– 353. 99 Kuutti-Savolainen ER, Risteli J, Miettinen TA, et al. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. I. Prolyl hydroxylase. Eur J Clin Invest 1979; 9: 89– 95. 100 Kuutti-Savolainen ER, Anttinen H, Miettinen TA, et al. Collagen biosynthesis enzymes in serum and hepatic tissue in liver disease. II. Galactosylhydroxylysyl glucosyltransferase. Eur J Clin Invest 1979; 9: 97– 101. 101 Rojkind M, Martinez Palomo A. Increase in type I and type III collagens in human alcoholic liver cirrhosis. Proc Natl Acad Sci USA 1976; 73: 539– 543. 102 Hirayama C, Morotomi I, Hiroshige K. Quantitative and metabolic changes of hepatic collagens in rats after carbon tetrachloride poisoning. Biochem J 1970; 118: 229– 232. 103 Nakamura N, Fusamoto H, Koizumi T. The effects of aminoace-tonitrile and its derivative on components of hepatic connective tissue in rats with chronic hepatic injury. Acta Hepato-Gastroenterol 1975; 22: 78– 84. 104 Feinman L, Fecher R, Shih-Lin L, et al. Aldehyde content of collagen from alcoholic cirrhotic and noncirrhotic human livers. Exp Mol Pathol 1979; 30: 271– 278. 105 Cannon DJ, Davison PF. Cross-linking and aging in rat tendon collagen. Exp Gerontol 1973; 8: 51– 62. 106 Vacinikova O, Deyl Z. Aging of connective tissue. Solubilization of collagen from animals varying in age and species by reagents capable of splitting adimine bonds. Exp Gerontol 1973; 8: 297– 306. 107 Perez Tamayo R. Pathology of collagen degradation. Am J Pathol 1978; 92: 509– 566. 108 Rojkind M, Giambrone MA, Takahashi S. Collagen polymorphism in normal and fibrotic liver. J Univ Occupat Environ Health 1982; 4 (Suppl.): 157– 168. 109 Hoffmann-Blume E, Fricke RJ, Hahn O. Das Verhalten von Kollagenopeptidase. Aktivität in der Rattenleber bei chroniseher CCI4-Schädigung. Z Rheumaforsch 1973; 32: 460– 467. 110 Okazaki I, Oda M, Maruyama K, et al. Mechanism of collagen resorption in experimental hepatic fibrosis. With special reference to the activity of lysosomal enzymes. Biochem Exp Biol 1974; 11: 15– 28. 111 Murawaki Y, Hirayama C. Hepatic collagenolytic cathepsin in patients with chronic liver disease. Clin Chim Acta 1980; 108: 121– 128. 112 Fujiwara K, Sakai T, Oda T, et al. The presence of coUagenase in Kupffer cells of the rat liver. Biochem Biophys Res Comm 1973; 54: 531– 537. 113 Fujiwara K, Sakai T, Oda T, et al. Demonstration of coUagenase activity in rat liver homogenate. Biochim Biophys Res Comm 1974; 60: 166– 171. 114 Pérez Tamayo R, Montfort I, González E, et al. CoUagenase in cirrhosis of the liver. In: M Tsuchiya, I Okazaki, R Perez Tamayo, eds. Tokyo Symposium: collagen destruction and mammalian coUagenase. Amsterdam: Excerpta Medica, 1984 (in press). 115 Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 1962; 48: 1014– 1022. 116 Okazaki I, Maruyama K. CoUagenase activity in experimental hepatic fibrosis. Nature 1974; 252: 49– 50. 117 Montfort I, Perez Tamayo R. CoUagenase in experimental carbon tetrachloride cirrhosis of the liver. Am J Pathol 1978; 92: 411– 420. 118 Maruyama K, Okazaki I, Kashiwazaki K, et al. Different appearance of hepatic coUagenase and lysosomal enzymes in recovery of experimental hepatic fibrosis. Biochem Exp Biol 1978; 14: 191– 201. 119 Okazaki I, Maruyama K. Mammalian coUagenase in the process of hepatic fibrosis. J Univ Occupat Environ Health 1980; 2: 401– 424. 120 Maruyama K, Feinman L, Okazaki I, et al. Direct measurement of neutral coUagenase activity in homogenates from baboon and human liver. Biochim Biophys Acta 1981; 658: 124– 131. 121 Pérez-Tamayo R, Montfort I. The susceptibility of hepatic collagen to homologous coUagenase in human and experimental cirrhosis of the liver. Am J Pathol 1980; 100: 427– 440. 122 Ryan JN, Woessner JF. Mammalian collagenase: direct demonstration in homogenates of involuting rat uterus. Biochim Biophys Res Comm 1971; 44: 144– 149. 123 Woessner JF, Ryan JN. Collagenase activity in homogenates of the involuting rat uterus. Biochim Biophys Acta 1973; 309: 397– 405. 124 Hayashi T, Nakamura T, Hori H, et al. Degradation rate of type II and type III collagens by tadpole collagenase are modulated by mutual presence. J Biochem 1980; 87: 993– 995. 125 Sunada H, Hayashi T, Hori H, et al. Dual effects of type II collagen on the degradation of type I collagen by tadpole collagenase. Coll Res 1981; 1: 177– 185. 126 Vadillo F, Pérez-Tamayo R. Colagenasa en cirrosis hepática hu-mana. Rev Invest Clin (Mexico) 1980; 32: 145– 172. Citing Literature Volume3, Issue11983Pages 112-120 ReferencesRelatedInformation
Referência(s)